Retractable Technologies Inc (RVP)
0.751
+0.01
(+0.81%)
USD |
NYAM |
Oct 04, 16:00
0.7419
-0.01
(-1.21%)
After-Hours: 20:00
Retractable Technologies SG&A Expense (Annual): 20.01M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 20.01M |
December 31, 2022 | 28.58M |
December 31, 2021 | 21.86M |
December 31, 2020 | 12.36M |
December 31, 2019 | 10.65M |
December 31, 2018 | 11.19M |
December 31, 2017 | 13.01M |
December 31, 2016 | 12.82M |
December 31, 2015 | 13.17M |
December 31, 2014 | 13.56M |
December 31, 2013 | 15.40M |
December 31, 2012 | 14.24M |
Date | Value |
---|---|
December 31, 2011 | 14.18M |
December 31, 2010 | 17.93M |
December 31, 2009 | 23.19M |
December 31, 2008 | 17.60M |
December 31, 2007 | 16.86M |
December 31, 2006 | 13.30M |
December 31, 2005 | 10.75M |
December 31, 2004 | 12.48M |
December 31, 2003 | 9.766M |
December 31, 2002 | 8.576M |
December 31, 2001 | 8.780M |
December 31, 2000 | 10.37M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
10.65M
Minimum
2019
28.58M
Maximum
2022
18.69M
Average
20.01M
Median
2023
SG&A Expense (Annual) Benchmarks
Plus Therapeutics Inc | 8.544M |
Perspective Therapeutics Inc | 21.06M |
InfuSystems Holdings Inc | 58.03M |
Xtant Medical Holdings Inc | 64.29M |
Catheter Precision Inc | 17.12M |